SPRY – ars pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ARS Pharmaceuticals, Inc. (SPRY) Expected to Beat Earnings Estimates: Can the Stock Move Higher? [Yahoo! Finance]
ARS Pharmaceuticals (SPRY) was upgraded by Zacks Research from "strong sell" to "hold".
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2025 Financial Results and Participation at Upcoming Conferences
ARS Pharmaceuticals: Climbing Neffy Sales And Global Expansion Could Re-Rate The Stock [Seeking Alpha]
ARS Pharmaceuticals to Showcase Scientific Innovation and Robust Clinical Data on neffy® (epinephrine nasal spray) at 2026 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Scientific Meeting
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: Rubric Capital Management LP
Form SCHEDULE 13G ARS Pharmaceuticals, Filed by: BlackRock, Inc.
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Scott Kathleen D.
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Karas Eric
Form 4 ARS Pharmaceuticals, For: Jan 02 Filed by: Fitzpatrick Alexander A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.